Related Research Articles
Duloxetine, sold under the brand name Cymbalta among others, is a medication used to treat major depressive disorder, generalized anxiety disorder, fibromyalgia, neuropathic pain and central sensitization. It is taken by mouth.
Stanozolol, sold under many brand names, is an androgen and anabolic steroid (AAS) medication derived from dihydrotestosterone (DHT). It is used to treat hereditary angioedema. It was developed by American pharmaceutical company Winthrop Laboratories in 1962, and has been approved by the U.S. Food and Drug Administration for human use, though it is no longer marketed in the USA. It is also used in veterinary medicine. Stanozolol has mostly been discontinued, and remains available in only a few countries. It is given by mouth in humans or by injection into muscle in animals.
Shlomo S. Sawilowsky was professor of educational statistics and Distinguished Faculty Fellow at Wayne State University in Detroit, Michigan, where he has received teaching, mentoring, and research awards.
Cytel is a multinational statistical software developer and contract research organization, headquartered in Cambridge, Massachusetts, USA. Cytel provides clinical trial design, implementation services, and statistical products primarily for the biotech and pharmaceutical development markets.
Lee-Jen Wei is a Taiwanese-American professor of biostatistics at Harvard University.
David Bennett Madigan is an Irish-American statistician and academic. He is currently Provost and Senior Vice-President for Academic Affairs at Northeastern University. Previously he was Professor of Statistics at Columbia University. From 2013 to 2018 he was also the Executive Vice-President for Arts and Sciences and Dean of the Faculty of Arts and Sciences and from 2008 to 2013 he served as Chair of the Department of Statistics, both at Columbia University. He was Dean of Physical and Mathematical Sciences at Rutgers University (2005-2007), Director of the Institute of Biostatistics at Rutgers University (2003-2004), and Professor in the Department of Statistics at Rutgers University (2001-2007).
Catherine A. "Kate" Calder is an American statistician who works as chair of Statistics and Data Sciences at the University of Texas at Austin. She was previously a professor of statistics at Ohio State University. Calder earned a bachelor's degree in mathematics from Northwestern University in 1999, and completed her Ph.D. in statistics from Duke University in 2003 under the joint supervision of David Higdon and Michael L. Lavine. She joined the Ohio State faculty in 2003, and was promoted to full professor in 2015.
Lila Knudsen Randolph was the chief statistician at the Food and Drug Administration and a Fellow of the American Statistical Association. At the FDA, her work involved statistical sampling of food and drugs, and "she was instrumental in developing practical applications of statistics in the validation of analytical methods". She also did early work in computational statistics, writing in the Journal of the American Statistical Association in 1942 about the use of punched cards to construct orthogonal polynomials.
Telba Zalkind Irony is a Brazilian statistician, operations researcher, and proponent of Bayesian statistics. She works at the Food and Drug Administration, where she was formerly chief of biostatistics at the Office of Device Evaluation and is now deputy directory of biostatistics and epidemiology at the Center for Biologics Evaluation and Research.
Lecanemab, sold under the brand name Leqembi, is a monoclonal antibody medication used for the treatment of Alzheimer's disease. Lecanemab is an amyloid beta-directed antibody. It is given via intravenous infusion. The most common side effects of lecanemab include headache, infusion-related reactions and amyloid-related imaging abnormalities, a side effect known to occur with the class of antibodies targeting amyloid.
Lisa Morrissey LaVange is Professor and Chair of the Department of Biostatistics in the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill where she directs the department’s Collaborative Studies Coordinating Center (CSCC), overseeing faculty, staff, and students involved in large-scale clinical trials and epidemiological studies coordinated by the center. She returned to her alma mater in 2018 after serving as the director of the Office of Biostatistics in the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER). Her career also includes 16 years in non-profit research and 10 years in the pharmaceutical industry. She served as the 2007 president of the Eastern North American Region (ENAR) of the International Biometric Society (IBS), and as the 2018 American Statistical Association (ASA) president.
Dionne L. Price is an American statistician who works as a division director in the Office of Biostatistics of the Center for Drug Evaluation and Research, in the US Food and Drug Administration. Her division provides statistical advice "used in the regulation of anti-infective, anti-viral, ophthalmology, and transplant drug products".
Susan S. Ellenberg is an American statistician specializing in the design of clinical trials and in the safety of medical products. She is a professor of biostatistics, medical ethics and health policy in the Perelman School of Medicine at the University of Pennsylvania. She was the 1993 president of the Society for Clinical Trials and the 1999 President of the Eastern North American Region of the International Biometric Society.
Ralph Benedict D'Agostino Sr. is an American biostatistician and professor of Mathematics/Statistics, Biostatistics and Epidemiology at Boston University. He was the director of the Statistics and Consulting Unit of the Framingham Study and the executive director of the M.A./Ph.D. program in biostatistics at Boston University. He was elected a fellow of the American Statistical Association in 1990 and of the American Heart Association in 1991.
Jana Lynn Asher is a statistician known for her work on human rights and sexual violence. She is an Associate Professor of Mathematics and Statistics at Slippery Rock University. She was a co-editor of the book Statistical Methods for Human Rights with David L. Banks and Fritz Scheuren.
In an adaptive design of a clinical trial, the parameters and conduct of the trial for a candidate drug or vaccine may be changed based on an interim analysis. Adaptive design typically involves advanced statistics to interpret a clinical trial endpoint. This is in contrast to traditional single-arm clinical trials or randomized clinical trials (RCTs) that are static in their protocol and do not modify any parameters until the trial is completed. The adaptation process takes place at certain points in the trial, prescribed in the trial protocol. Importantly, this trial protocol is set before the trial begins with the adaptation schedule and processes specified. Adaptions may include modifications to: dosage, sample size, drug undergoing trial, patient selection criteria and/or "cocktail" mix. The PANDA provides not only a summary of different adaptive designs, but also comprehensive information on adaptive design planning, conduct, analysis and reporting.
Bamlanivimab is a monoclonal antibody developed by AbCellera Biologics and Eli Lilly as a treatment for COVID-19. The medication was granted an emergency use authorization (EUA) by the US Food and Drug Administration (FDA) in November 2020, and the EUA was revoked in April 2021.
Mikyoung Jun is a Korean-American statistician whose research topics have included the covariance of non-stationary spatial models, and applications in atmospheric science and climate modeling as well as to understanding the spatiotemporal patterns of global terrorism. She is ConocoPhillips Professor of Data Science in the Department of Mathematics of the University of Houston.
Lalitha (Lilly) Padman Sanathanan is an Indian statistician.
References
- ↑ Sherman, Rachel E.; Anderson, Steven A.; Pan, Gerald J. Dal; Gray, Gerry W.; Gross, Thomas; Hunter, Nina L.; LaVange, Lisa; Marinac-Dabic, Danica; Marks, Peter W.; Robb, Melissa A.; Shuren, Jeffrey; Temple, Robert; Woodcock, Janet; Yue, Lilly Q.; Califf, Robert M. (December 2016), "Real-World Evidence – What Is It and What Can It Tell Us?", New England Journal of Medicine, 375 (23): 2293–2297, doi:10.1056/nejmsb1609216
- 1 2 Dr Lilly Yue joins the Editorial Team of Pharmaceutical Statistics in 2021 (PDF), Wiley, retrieved 2023-09-06
- 1 2 "Candidates for Directors of ICSA Board (2015–2017): 9. YUE, Lilly" (PDF), International Chinese Statistical Association Bulletin, 26 (2): 82, July 2014, retrieved 2023-09-06
- ↑ Academic program review: Department of Statistics at Texas A&M University (PDF), Texas A&M University, 2022, p. 295, retrieved 2023-09-06
- ↑ ASA Fellows, American Statistical Association, retrieved 2023-09-06
- ↑ Excellence in Data Science Group Award 2009–Present, Food and Drug Administration, retrieved 2023-09-06